436 related articles for article (PubMed ID: 25427263)
1. Survey of Korean dentists on the awareness on bisphosphonate-related osteonecrosis of the jaws.
Yoo JY; Park YD; Kwon YD; Kim DY; Ohe JY
J Investig Clin Dent; 2010 Nov; 1(2):90-5. PubMed ID: 25427263
[TBL] [Abstract][Full Text] [Related]
2. Knowledge, practices, and opinions of ontario dentists when treating patients receiving bisphosphonates.
Alhussain A; Peel S; Dempster L; Clokie C; Azarpazhooh A
J Oral Maxillofac Surg; 2015 Jun; 73(6):1095-105. PubMed ID: 25843818
[TBL] [Abstract][Full Text] [Related]
3. Survey on awareness and perceptions of bisphosphonate-related osteonecrosis of the jaw in dental hygienists in Seoul.
Mah YJ; Kang GY; Kim SJ
Int J Dent Hyg; 2015 Aug; 13(3):222-7. PubMed ID: 25677614
[TBL] [Abstract][Full Text] [Related]
4. The awareness and practice of dentists regarding medication-related osteonecrosis of the jaw and its prevention: a cross-sectional survey.
Han AL
BMC Oral Health; 2021 Mar; 21(1):155. PubMed ID: 33761923
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonate-associated Osteonecrosis of the Jaws: a Survey of the Level of Knowledge of Dentists about the Risks of Bisphosphonate Therapy.
Hristamyan-Cilev MA; Pechalova PP; Raycheva RD; Hristamyan VP; Kevorkyan AK; Stoilova YD
Folia Med (Plovdiv); 2019 Jun; 61(2):303-311. PubMed ID: 31301653
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
Grant BT; Amenedo C; Freeman K; Kraut RA
J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
[TBL] [Abstract][Full Text] [Related]
7. A survey of consultant members of the British Association of Oral and Maxillofacial Surgeons regarding bisphosphonate-induced osteonecrosis of the jaws.
Rogers SN; Hung J; Barber AJ; Lowe D
Br J Oral Maxillofac Surg; 2009 Dec; 47(8):598-601. PubMed ID: 19748711
[TBL] [Abstract][Full Text] [Related]
8. Medical and Dental Professions' Varying Levels of Awareness Regarding Medication-related Osteonecrosis of the Jaw in Saudi Arabia? A Cross-sectional Study.
Aljohani MH; Aljohani AS; Aljohani RM; Alsharif WK; Nourwali I; Elsayed SA
J Contemp Dent Pract; 2024 Jan; 25(1):62-67. PubMed ID: 38514433
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for medication-related osteonecrosis of the jaw and salivary IL-6 IN cancer patients.
Kemp APT; Ferreira VHC; Mobile RZ; Brandão TB; Sassi LM; Zarpellon A; Braz-Silva PH; Schussel JL
Braz J Otorhinolaryngol; 2022; 88(5):683-690. PubMed ID: 33189595
[TBL] [Abstract][Full Text] [Related]
10. Dental implications of bisphophonate-related osteonecrosis.
Saldanha S; Shenoy VK; Eachampati P; Uppal N
Gerodontology; 2012 Sep; 29(3):177-87. PubMed ID: 22486711
[TBL] [Abstract][Full Text] [Related]
11. [Bisphosphonate-related osteonecrosis of the jaw-after a decade has passed].
Yoneda T
Clin Calcium; 2014 Mar; 24(3):407-15. PubMed ID: 24576938
[TBL] [Abstract][Full Text] [Related]
12. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
Assael LA
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813
[TBL] [Abstract][Full Text] [Related]
13. How concerns for bisphosphonate-induced osteonecrosis of the jaw affect clinical practice among dentists: a study from the South Texas Oral Health Network.
Gonzales CB; Young V; Ketchum NS; Bone J; Oates TW; Mungia R
Gen Dent; 2015; 63(2):61-7. PubMed ID: 25734289
[TBL] [Abstract][Full Text] [Related]
14. [Bisphosphonate and denosumab-related osteonecrosis of the jaw: Epidemiology, diagnosis and management].
Dupic G; Collangettes D; Dillies AF; Calvet L; Tournilhac O; Bay JO; Mahammedi H
Bull Cancer; 2015 Dec; 102(12):1010-9. PubMed ID: 26607453
[TBL] [Abstract][Full Text] [Related]
15. Physicians' awareness of bisphosphonates-related osteonecrosis of the jaw.
Al-Mohaya MA; Al-Khashan HI; Mishriky AM; Al-Otaibi LM
Saudi Med J; 2011 Aug; 32(8):830-5. PubMed ID: 21858393
[TBL] [Abstract][Full Text] [Related]
16. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.
Khan AA; Sándor GK; Dore E; Morrison AD; Alsahli M; Amin F; Peters E; Hanley DA; Chaudry SR; Dempster DW; Glorieux FH; Neville AJ; Talwar RM; Clokie CM; Al Mardini M; Paul T; Khosla S; Josse RG; Sutherland S; Lam DK; Carmichael RP; Blanas N; Kendler D; Petak S; St-Marie LG; Brown J; Evans AW; Rios L; Compston JE;
J Rheumatol; 2008 Jul; 35(7):1391-7. PubMed ID: 18528958
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonates, healthcare professionals and oral health.
Raj DV; Abuzar M; Borromeo GL
Gerodontology; 2016 Mar; 33(1):135-43. PubMed ID: 25039439
[TBL] [Abstract][Full Text] [Related]
18. The trend of dental check-up and prevalence of dental complications following the use of bone modifying agents in patients with metastatic breast and prostate cancer: analysis of data from the Korean National Health Insurance Service.
Lim AR; Park W; Moon SJ; Kim MS; Lee S
BMC Health Serv Res; 2024 Apr; 24(1):412. PubMed ID: 38566103
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonate-induced osteonecrosis of the jaw: a medical enigma?
Siddiqi A; Payne AG; Zafar S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):e1-8. PubMed ID: 19570696
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonate-related osteonecrosis of the jaws--a case report.
Kamoh AK; Ogle O
Compend Contin Educ Dent; 2012 May; 33(5):e74-7. PubMed ID: 23268588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
